Brief: FDA Designates Breakthrough Device Status For Mynd Analytics’ Peer 4.0
17/09/2018 20:46
Sept 17 (Reuters) - MYnd Analytics Inc MYND.O :
* FDA DESIGNATES BREAKTHROUGH DEVICE STATUS FOR MYND
ANALYTICS’
PEER 4.0
Source text for Eikon: ID:nGNX4kjnt9
Further company coverage: MYND.O
((Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns